Genmab launches “AI Everywhere”

Genmab⁠(opens in a new window), a leading global biotechnology company, is pioneering next-generation antibody therapies to treat cancer and other serious diseases. Their mission is ambitious: to revolutionize patient care with transformative “knock-your-socks-off” (KYSO^®) antibody treatments. 

“Genmab’s ambition is to integrate AI into everything we do,” said Tahi Ahmadi, Executive Vice President and Chief Medical Officer, Head of Experimental Medicines. “We anticipated AI to contribute significantly to the quality of our science, decision making, and efficiency in bringing medicines to patients.”

Adopting ChatGPT across operations

As a company that has recently tripled in size, Genmab wanted to use AI to address operational challenges—and develop new ways of working with vast amounts of complex scientific data. 

As part of its strategic vision to innovate and leverage AI, Genmab identified a unique opportunity to partner with ChatGPT by launching its Enterprise offering and rolling it out to 1,000 employees. Now, less than a year later, they’ve launched “AI Everywhere” to give ChatGPT access to almost everyone at the company—more than 2,000 licenses.

To provide a starting point for employees, Genmab had a simple but effective idea: they encouraged employees to give ChatGPT Enterprise their job description and ask, “What can you do to help me?”

By scaling the adoption of tools like ChatGPT, Genmab invests in every employee’s continuous learning journey. 

“Learning to use ChatGPT has been a transformative journey for our employees. Our comprehensive training programs and personalized guidance have empowered them to embrace innovative ways of thinking and problem-solving.”

Farhat Siddiqui, ChatGPT Product Manager at Genmab

In a recent survey, employees reported that ChatGPT Enterprise saves them an average of 3.5 hours per week, and many could not imagine performing aspects of their jobs without these newfound capabilities.